Acorda Therapeutics, Inc.

ACORNASDAQHealthcare

$0.66

$-0.21(-24.02%)

Market Cap$821028

P/E Ratio—

52W High$24.2

52W Low$0.6116

Avg Volume140K

Open$0.78

Beta1.46

Forecast Market Cap PE Ratio

Acorda Therapeutics, Inc.（ACOR）股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

acor · 股价预测 · 19 位分析师（近3月）· FMP · 更新于 2025年6月4日

分析师评级与共识

基于过去 3 个月内 19 位华尔街分析师

Hold

19 位分析师

共识

评级分布

Strong Buy

Buy

Hold

Sell

Strong Sell

合计: 19 · 买入占比: 26.3%

12 个月目标价

High

$0.00

Consensus

$0.00

+0.0% upside

Low

$0.00

Median: $0 · Last Close: $0.88

Acorda Therapeutics, Inc.（ACOR）的分析师共识为 Hold，基于过去 3 个月内 19 位华尔街分析师的评级。ACOR 的 12 个月平均目标价为 $0.00，相对当前价 $0.88 代表 +0.0% 的潜在上行空间。

短期股价预测

Bear

算法生成 · 每日更新

Date	Predicted Price	Change	Min	Max
2026-06-09	$0.92	↑ 5.00%	$0.89	$0.96

1-day model range: $0.89–$0.96. Peak: $0.96 (+5.00%).

长期股价预测

年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031

Year	Low	Avg Price	High	Change
2027	$0	$0	$1	-50.0%
2028	$0	$0	$0	-62.5%
2029	$0	$0	$0	-67.2%
2030	$0	$0	$0	-69.2%
2031	$0	—	$0	-70.2%

Confidence:Medium

基于技术分析的股价预测

14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明

Market Sentiment

BEARISH

Based on 14 technical indicators

43%0%57%

6Buy

0Neutral

8Sell

RSI (14)75.0Overbought

MACDBEARISH

Refreshes daily from EOD close

Moving Averages · ACOR · Jun 9, 2026

Simple Moving Average (SMA)

MA 5$0.85BUY

MA 10$0.79BUY

MA 20$0.64BUY

MA 50$1.48SELL

MA 100$2.02SELL

MA 200$2.07SELL

Current $ACOR · Price above MA = BUY signal

Exponential Moving Average (EMA)

EMA 5$0.83BUY

EMA 10$0.79BUY

EMA 20$0.87BUY

EMA 50$1.32SELL

EMA 100$1.68SELL

EMA 200$1.94SELL

Current $ACOR · Price above MA = BUY signal

How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

最新分析师评级与调整

Filter:

Date	Brokerage	Action	Rating
2021-06-17	HC Wainwright & Co.	Upgrade ↑	Neutral→Buy
2020-05-06	H.C. Wainwright	Maintains	Neutral→Neutral
2019-10-24	JP Morgan	Downgrade ↓	Neutral→Underweight
2019-08-14	H.C. Wainwright	Downgrade ↓	Buy→Neutral
2019-08-02	Wedbush	Maintains	Neutral→Neutral
2019-08-02	Stifel	Maintains	Hold→Hold
2019-05-23	Wedbush	Maintains	Neutral→Neutral
2018-12-11	Goldman Sachs	Downgrade ↓	Neutral→Sell
2018-10-05	Stifel Nicolaus	Maintains	Hold→Hold
2018-08-23	Cantor Fitzgerald	Maintains	Neutral→Neutral

HC Wainwright & Co.2021-06-17

Upgrade ↑

Neutral→Buy

H.C. Wainwright2020-05-06

Maintains

Neutral→Neutral

JP Morgan2019-10-24

Downgrade ↓

Neutral→Underweight

H.C. Wainwright2019-08-14

Downgrade ↓

Buy→Neutral

Wedbush2019-08-02

Maintains

Neutral→Neutral

Stifel2019-08-02

Maintains

Hold→Hold

Wedbush2019-05-23

Maintains

Neutral→Neutral

Goldman Sachs2018-12-11

Downgrade ↓

Neutral→Sell

Stifel Nicolaus2018-10-05

Maintains

Hold→Hold

Cantor Fitzgerald2018-08-23

Maintains

Neutral→Neutral

Wall Street analysts have recently issued updated ratings on Acorda Therapeutics, Inc. (ACOR) stock. Of the recent 44 rating actions, 5 were upgrades and 8 were downgrades. 19 analysts currently cover ACOR.

分析师推荐趋势

Buy ratings0 → 1↑ +1

Hold ratings0 → 0

Sell ratings1 → 0↓ 1

ACOR analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 1 per month.

财务预测：EPS 与营收一致预期

Revenue This Year

$120M

↑ 8.5% YoY

Revenue Next Year

$121M

↑ 0.1% YoY

EPS This Year

$-152.80

EPS Next Year

$-19.20

↓ 87.4% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast ACOR EPS of $-152.80 for the current fiscal year, based on estimates from 13 analysts. The ACOR revenue forecast is $120M for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

ACOR 股价预测由两类独立数据源支撑：来自 19 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。ACOR 的共识目标价为 $0.00（+0.0% 上行空间），分析师共识为 Hold。

ACOR 的短期预测（明日）为 $0.92（+5.00%）。 ACOR 对 2027 年的股价预测均值为 $0。 ACOR 对 2030 年的预测区间为 $0–$0。

Acorda Therapeutics, Inc. 在 NASDAQ 上市，代码 ACOR。ACOR 在 2027 年的整体展望偏中性/分化，在覆盖分析师中约 26% 对应 Hold 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

常见问题

ACOR 预测 · 8 个问题

根据 19 位华尔街分析师，ACOR 的 12 个月平均目标价为 $0.00，最高 $0.00、最低 $0.00。若有图表，中位目标价可在上方查看。相对当前价 $0.88，隐含约 +0.0% 的上行空间。

ACOR 目标价ACOR 分析师目标价ACOR 12个月目标价目标价 ACOR

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.